Isoflurane and propofol block neurotoxicity caused by MK-801 in the rat posterior cingulate/retrosplenial cortex

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 2, 1997, Pages 168-174

  Jevtović Todorović, Vesna ^a   Kirby, Charity O ^a   Olney, John W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Isoflurane; Neurotoxicity; NMDA antagonists; Propofol; Rat

Indexed keywords

DIZOCILPINE; ISOFLURANE; N METHYL DEXTRO ASPARTIC ACID; PROPOFOL;

ANIMAL EXPERIMENT; ARTICLE; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0342813086     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199702000-00006     Document Type: Article

References (40)

1. Adam HK, Glen JB, Hoyle PA (1980) Pharmacokinetics in laboratory animals of ICI 35868, a new i.v. anaesthetic agent. Br J Anaesthesiol 52:743-746
2. Alquander C. (1978) Dependence on sedative and hypnotic drugs. Acta Psychiatr Scand 270:1-120
3. Bailie GR, Cockshott ID, Douglas EJ, Bowles BJM (1992) Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesthesiol 68:486-491
4. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC (1988) Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesthesiol 61:583-588
5. Borgeat A, Wilder-Smith OHG, Suter PM (1994) The nonhypnotic therapeutic applications of propofol. Anesthesiology 80: 642-656
6. Choi DW (1988) Glutamate neurotoxicity and disease of the nervous system. Neuron 1:623-634
7. Cockshott ID (1985) Propofol ('Diprivan') pharmacokinetics and metabolism - an overview. Postgrad Med J 61(suppl 3): 45-50
8. Corso TD, Wozniak DF, Sesma MA, Olney JW (1994) Neuron necrotizing properties of phencyclidine [Abstract]. Soc Neurosci Abst 20:1531
9. Domino E, Luby E (1981) Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: PCP (Phencyclidine): Historical and Current Perspectives. (Domino E, ed), Ann Arbor, NPP Books, pp 401-418
10. Faden AI, Demediuk P, Panter SS, Vink R (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800
11. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GC, Storts RW, Farber NB, Wozniak DF, Olney JW (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (Dizocilipine Maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123:204-215
12. Fragen RJ, Avram MJ (1992) Nonopioid intravenous anesthetics. In: Clinical Anesthesia (Barash PG, Cullen BF, Stoelting RK, eds), Philadelphia, J.B. Lippincott Co, p 402
13. Franks NP, Lieb WR (1994) Molecular and cellular mechanisms of general anaesthesia. Nature 367:607-614
14. Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, Murphy D, LaRue L (1995) Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 26:602-605
15. A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 79: 781-788
16. Hargreaves RJ, Rigby M, Smith D, Hill RG, Iversen LL (1993) Competitive as well as uncompetitive NMDA receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism. Neurochem Res 18:1,263-1,269
17. Herregods L, Mergaert C, Rolly G (1989) Comparison of the effects of 24-hour propofol or fentanyl infusions on intracranial pressure. J Drug Devel 2(suppl 2):99-100
18. Herrling PL (1994) D-CPPene (SDZ EAA 494), A competitive NMDA antagonist: results from animal models and first results in humans. Neuropsychopharmacology 10:no 3S/part 1:591S
19. Hucker HB, Hutt JE, White SD, Arison BH, Zacchei AG (1982) Disposition and metabolism of (+)-5-methyl-10,1-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab Disposition 11:54-58
20. Ishimaru M, Fukamauchi F, Olney JW (1995) Halothane prevents MK-801 neurotoxicity in the rat cingulate cortex. Neurosci Lett 193:1-4
21. Kristensen JD, Svensson B, Gordth T (1992) The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51:249-253
22. Krystal JH, Karper LP, Seibyl JP, Delaney R, Bremner JD, Bowers MB, Charney DS (1992) Dose-related effects of the NMDA antagonist, Ketamine, in healthy humans. Schizophrenia Res 9:240-241
23. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF (1962) Model psychoses and schizophrenia. Am J Psychiatry 119:61-67
24. Madsen JB, Cold GE, Hansen ES (1987) Cerebral blood flow and metabolism during isoflurane-induced hypotension in patients subjected to surgery for cerebral aneurysms. Br J Anaesthesiol 59:1204-1207
25. Magbagbeola JAO, Thomas NA (1974) Effects of thiopentone on emergence reactions to ketamine anaesthesia. Can Anaesthesiol Soc J 21:321-324
26. McCulloch J (1992) Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. Br J Clin Pharmacol 34:106-114
27. Muir KW, Lees KR (1995) Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513
28. Nakahiro M, Ych JZ, Brunner E, Narahashi T (1989) General anesthetics modulate GABA receptor channel complex in rat dorsal root ganglion neurons. FASEB J 3:1850-1854
29. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1,360-1,362
30. Olney JW, Labruyere J, Wang G, Sesma MA, Wozniak DF, Price MT (1991) NMDA antagonist neurotoxicity: mechanism and protection. Science 254:1,515-1,518
31. Olney JW, Farber NB (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins and research tools for studying schizophrenia. Neuropsychopharmacology 12: 347-349
32. Pinaud M, Lelausque JN, Fauchoux N, Chetanneau A, Chomarat P (1988) Effects of propofol on cerebral hemodynamics and metabolism in patients with head trauma [Abstract]. Anesthesiology 69(3):A569
33. Plainer B, Weinstabl C, Spiss CK (1989) Propofol vs. midazolam in combination with sufentanil for continuous sedation in the neurosurgical ICU. J Drug Devel 2(suppl 2): 101-103
34. Reich DL, Silvay G (1989) Ketamine: an update on the first twenty years of clinical experience. Can J Anaesthesiol 36:186-197
35. Shyr MH, Tsai TH, Tan PP, Chen CF and Chan SH (1995) Concentration and regional distribution of propofol in brain and spinal cord during propofol anesthesia in the rat. Neurosci Lett 184:212-215
36. Stevens WC, Kingston HGG (1992) Inhalation anesthesia. In: Clinical Anesthesia (Barash PG. ed), Philadelphia, J.B. Lippincott Co., pp 439-465
37. Veselis RA, Reinsel RA, Marino P, Wronski M (1991) EEG power spectrum changes during propofol sedation [Abstract]. Anesthesiology 75:A181
38. Weinstabl C, Mayer N, Hammerle AF (1990) Effects of propofol bolus doses on intracranial pressure in head injuries. Anaesthetist 39:521-524
39. Yamakura T, Sakimura K, Shimoji K, Mishina M (1995) Effects of propofol on various AMPA-, kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci Lett 188:187-190
40. Yang CH, Shyr MH, Kuo TB, Tan PP, Chan SH (1995) Effects of propofol on nociceptive response and power spectra of electroencephalographic and systemic arterial pressure signals in the rat: correlation with plasma concentration. J Pharmacol Exp Ther 275:1,568-1,574